Cabozantinib for different endocrine tumours: killing two birds with one stone. A systematic review of the literature von Zago, Elena, Galluzzo, Antonio, Pradella, Silvia, Antonuzzo, Lorenzo, Maggi, Mario, Petrone, Luisa, Sparano, Clotilde

Volltext

Corrigendum to “The emerging HER2 landscape in Colorectal Cancer: The key to unveil the future treatment algorithm?” [Crit. Rev. Oncol./Hematol. 204 (2024) 104515] von Antonuzzo, Lorenzo

Volltext

Everolimus in Pancreatic Neuroendocrine Carcinomas G3 von Panzuto, Francesco, Rinzivillo, Maria, Spada, Francesca, Antonuzzo, Lorenzo, Ibrahim, Toni, Campana, Davide, Fazio, Nicola, Delle Fave, Gianfranco

Volltext

Unconventional strategy could be the future: From target to KRAS broad range treatment von Fancelli, Sara, Petroni, Giulia, Pillozzi, Serena, Antonuzzo, Lorenzo

Volltext

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective von Lavacchi, Daniele, Pellegrini, Elisa, Palmieri, Valeria Emma, Doni, Laura, Mela, Marinella Micol, Di Maida, Fabrizio, Amedei, Amedeo, Pillozzi, Serena, Carini, Marco, Antonuzzo, Lorenzo

Volltext

Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis von Paderi, Agnese, Gambale, Elisabetta, Botteri, Cristina, Giorgione, Roberta, Lavacchi, Daniele, Brugia, Marco, Mazzoni, Francesca, Giommoni, Elisa, Bormioli, Susanna, Amedei, Amedeo, Pillozzi, Serena, Matucci Cerinic, Marco, Antonuzzo, Lorenzo

Volltext

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study von Loupakis, Fotios, Intini, Rossana, Cremolini, Chiara, Orlandi, Armando, Sartore-Bianchi, Andrea, Pietrantonio, Filippo, Pella, Nicoletta, Spallanzani, Andrea, Dell’Aquila, Emanuela, Scartozzi, Mario, De Luca, Emmanuele, Rimassa, Lorenza, Formica, Vincenzo, Leone, Francesco, Calvetti, Lorenzo, Aprile, Giuseppe, Antonuzzo, Lorenzo, Urbano, Federica, Prenen, Hans, Negri, Francesca, Di Donato, Samantha, Buonandi, Pasquale, Tomasello, Gianluca, Avallone, Antonio, Zustovich, Fable, Moretto, Roberto, Antoniotti, Carlotta, Salvatore, Lisa, Calegari, Maria Alessandra, Siena, Salvatore, Morano, Federica, Ongaro, Elena, Cascinu, Stefano, Santini, Daniele, Ziranu, Pina, Schirripa, Marta, Buggin, Federica, Prete, Alessandra Anna, Depetris, Ilaria, Biason, Paola, Lonardi, Sara, Zagonel, Vittorina, Fassan, Matteo, Di Maio, Massimo

Volltext

Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy von Rubino, Rossella, Marini, Andrea, Roviello, Giandomenico, Presotto, Elena Margherita, Desideri, Isacco, Ciardetti, Isabella, Brugia, Marco, Pimpinelli, Nicola, Antonuzzo, Lorenzo, Mini, Enrico, Livi, Lorenzo, Maggi, Mario, Peri, Alessandro

Volltext

Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles von Menconi, Alessio, Marzo, Tiziano, Massai, Lara, Pratesi, Alessandro, Severi, Mirko, Petroni, Giulia, Antonuzzo, Lorenzo, Messori, Luigi, Pillozzi, Serena, Cirri, Damiano

Volltext

Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report von Pilia, Antonino Marcello, Salvati, Lorenzo, Guidolin, Alessia, Mazzoni, Francesca, Antonuzzo, Lorenzo, Parronchi, Paola, Liotta, Francesco

Volltext

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study von Paderi, Agnese, Fancelli, Sara, Caliman, Enrico, Pillozzi, Serena, Gambale, Elisabetta, Mela, Marinella Micol, Doni, Laura, Mazzoni, Francesca, Antonuzzo, Lorenzo

Volltext

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing von Lavacchi, Daniele, Fancelli, Sara, Buttitta, Eleonora, Vannini, Gianmarco, Guidolin, Alessia, Winchler, Costanza, Caliman, Enrico, Vannini, Agnese, Giommoni, Elisa, Brugia, Marco, Cianchi, Fabio, Pillozzi, Serena, Roviello, Giandomenico, Antonuzzo, Lorenzo

Volltext

Results of the observational prospective RealFLOT study von Giommoni, Elisa, Lavacchi, Daniele, Tirino, Giuseppe, Fornaro, Lorenzo, Iachetta, Francesco, Pozzo, Carmelo, Satolli, Maria Antonietta, Spallanzani, Andrea, Puzzoni, Marco, Stragliotto, Silvia, Sisani, Michele, Formica, Vincenzo, Giovanardi, Filippo, Strippoli, Antonia, Prisciandaro, Michele, Di Donato, Samantha, Pompella, Luca, Pecora, Irene, Romagnani, Alessandra, Fancelli, Sara, Brugia, Marco, Pillozzi, Serena, De Vita, Ferdinando, Antonuzzo, Lorenzo

Volltext

Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma von Pasqui, Adriano, Boddi, Anna, Campanacci, Domenico Andrea, Scoccianti, Guido, Bernini, Andrea, Grasso, Daniela, Gambale, Elisabetta, Scolari, Federico, Palchetti, Ilaria, Palomba, Annarita, Fancelli, Sara, Caliman, Enrico, Antonuzzo, Lorenzo, Pillozzi, Serena

Volltext

Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study von Linguanti, Flavia, Abenavoli, Elisabetta M., Briganti, Vittorio, Danti, Ginevra, Lavacchi, Daniele, Matteini, Maria, Vaggelli, Luca, Novelli, Luca, Grosso, Anna M., Mungai, Francesco, Mini, Enrico, Antonuzzo, Lorenzo, Miele, Vittorio, Sciagrà, Roberto, Berti, Valentina

Volltext

Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas von Iorio, Jessica, Antonuzzo, Lorenzo, Scarpi, Emanuela, D’Amico, Massimo, Duranti, Claudia, Messerini, Luca, Sparano, Clotilde, Caputo, Damiano, Lavacchi, Daniele, Borzomati, Domenico, Antonelli, Alice, Nibid, Lorenzo, Perrone, Giuseppe, Coppola, Alessandro, Coppola, Roberto, di Costanzo, Francesco, Lastraioli, Elena, Arcangeli, Annarosa

Volltext

Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer von Lavacchi, Daniele, Roviello, Giandomenico, Guidolin, Alessia, Romano, Silvia, Venturini, Jacopo, Caliman, Enrico, Vannini, Agnese, Giommoni, Elisa, Pellegrini, Elisa, Brugia, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo

Volltext

FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial von Damato, Angela, Bergamo, Francesca, Antonuzzo, Lorenzo, Nasti, Guglielmo, Iachetta, Francesco, Romagnani, Alessandra, Gervasi, Erika, Larocca, Mario, Pinto, Carmine

Volltext

Regorafenib Also Can Cause Osteonecrosis of the Jaw von Antonuzzo, Lorenzo, Lunghi, Alice, Giommoni, Elisa, Brugia, Marco, Di Costanzo, Francesco

Volltext

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC... von Damato, Angela, Iachetta, Francesco, Antonuzzo, Lorenzo, Nasti, Guglielmo, Bergamo, Francesca, Bordonaro, Roberto, Maiello, Evaristo, Zaniboni, Alberto, Tonini, Giuseppe, Romagnani, Alessandra, Berselli, Annalisa, Normanno, Nicola, Pinto, Carmine

Volltext